| Ticker | $ Bought |
|---|---|
| tempus ai inc | 5,844,370 |
| Ticker | % Reduced |
|---|---|
| caredx inc | -29.56 |
| natera inc | -15.02 |
| guardant health inc | -7.61 |
| Ticker | $ Sold |
|---|---|
| akoya biosciences inc | -6,107,120 |
| 10x genomics inc-class a | -12,746,300 |
Blue Water Life Science Advisors, LP has about 94.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 94.7 |
| Others | 5.3 |
Blue Water Life Science Advisors, LP has about 20.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 40.8 |
| MID-CAP | 23.1 |
| LARGE-CAP | 20.8 |
| MICRO-CAP | 10 |
| UNALLOCATED | 5.3 |
About 63.9% of the stocks held by Blue Water Life Science Advisors, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 63.9 |
| Others | 36.1 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Blue Water Life Science Advisors, LP has 7 stocks in it's portfolio. CDNA proved to be the most loss making stock for the portfolio. ADPT was the most profitable stock for Blue Water Life Science Advisors, LP last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADPT | adaptive biotechnologies | 29.28 | 2,145,140 | 32,091,400 | unchanged | 0.00 | ||
| AKYA | akoya biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CDNA | caredx inc | 6.77 | 510,000 | 7,415,400 | reduced | -29.56 | ||
| GH | guardant health inc | 23.12 | 405,647 | 25,344,800 | reduced | -7.61 | ||
| NTRA | natera inc | 20.78 | 141,494 | 22,776,300 | reduced | -15.02 | ||
| PSNL | personalis inc | 9.97 | 1,676,300 | 10,929,500 | unchanged | 0.00 | ||
| QTRX | quanterix corp | 4.74 | 957,747 | 5,200,570 | unchanged | 0.00 | ||
| TXG | 10x genomics inc-class a | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| tempus ai inc | 5.33 | 72,412 | 5,844,370 | new | ||||